Data Catalogue

3TR

Identification of the molecular mechanisms of non-response to treatments, relapses and remission in autoimmune, inflammatory, and allergic conditions

Keywords IMI projects Respiratory diseases Autoimmune diseases Tools for predicting/monitoring efficacy Biobanks Disease taxonomy

Started: 2019-09-01
Website: http://3tr-imi.eu/

f0a4c754-5f11-11eb-917b-acde48001122

BIOMAP

Biomarkers in atopic dermatitis and psoriasis

Keywords IMI projects Autoimmune diseases Skin diseases Biobanks Disease taxonomy

Started: 2019-04-01
Website: http://biomap-imi.eu/

f3257b22-5f11-11eb-917b-acde48001122

BTCure

Be The Cure

Keywords IMI projects Autoimmune diseases Tools for predicting/monitoring safety Disease taxonomy

Started: 2011-04-01
Website: http://btcure.eu/

f5f48d98-5f11-11eb-917b-acde48001122

H2O

H2O Health outcomes observatory

Keywords IMI projects Diabetes & metabolic disorders Autoimmune diseases Cancer Patient involvement in R&D Real-world data, evidence

Started: 2020-10-01
Website: https://health-outcomes-o...

f25b22b4-5f11-11eb-917b-acde48001122

HIPPOCRATES

Health initiatives in psoriasis and psoriatic arthritis consortium European states

Keywords IMI projects Autoimmune diseases Skin diseases Biobanks Clinical networks Disease taxonomy +1 more

Started: 2021-07-01
Website: https://www.hippocrates-imi.eu/

c9016a1e-c98a-11ed-a11d-ea435b63c148

IDEA-FAST

Identifying digital endpoints to assess fatigue, sleep and activities in daily living in neurodegenerative disorders and immune-mediated inflammatory diseases

Keywords IMI projects Neurodegenerative diseases Autoimmune diseases Clinical trial design Digital health Real-world data, evidence

Started: 2019-11-01
Website: https://ideafast.eu/

f4fca6aa-5f11-11eb-917b-acde48001122

imSAVAR · Immune safety avatar: nonclinical mimicking of the immune system effects of immunomodulatory therapies

Certain treatments for cancers and autoimmune diseases work by altering the immune system. However, a major challenge for researchers is identifying potential efficacy and safety issues with these treatments early in drug development, before they are tested in humans. Part of the problem is that the tests used early in drug development do not reflect the full complexity of the human immune system. In addition, these tests tend to be based on a healthy immune system, which is different to the ...

Keywords IMI projects Immunology Autoimmune diseases Tools for predicting/monitoring efficacy Tools for predicting/monitoring safety